A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease. [electronic resource]
Producer: 20150224Description: 775-83 p. digitalISSN:- 1178-2005
- Adrenergic beta-2 Receptor Agonists -- adverse effects
- Adult
- Age Factors
- Aged
- Bronchodilator Agents -- adverse effects
- Budesonide -- adverse effects
- Chi-Square Distribution
- Cholinergic Antagonists -- adverse effects
- Comorbidity
- Cross-Sectional Studies
- Data Mining
- Databases, Factual
- Drug Combinations
- Drug Costs
- Ethanolamines -- adverse effects
- Female
- Formoterol Fumarate
- Glucocorticoids -- adverse effects
- Health Expenditures
- Humans
- Male
- Middle Aged
- Odds Ratio
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Scopolamine Derivatives -- adverse effects
- Sex Factors
- Time Factors
- Tiotropium Bromide
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.